UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000006532 |
|---|---|
| Receipt number | R000007721 |
| Scientific Title | A phase II study of Docetaxel with Bevacizumab for EGFR mutation negative previously treated non-squamous non-small cell lung cancer |
| Date of disclosure of the study information | 2011/10/14 |
| Last modified on | 2019/04/25 13:27:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/10/13 14:58:28 | ||
| 2 | Update | 2011/10/16 17:22:41 | Condition |
|
| 3 | Update | 2019/04/25 13:22:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code TEL Last name of contact person Last name of contact person Zip code TEL Name of primary person or sponsor Organization Organization Organization Organization Organization Address Address Tel |
|
| 4 | Update | 2019/04/25 13:27:50 | Recruitment status Date of IRB Last follow-up date |
